BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20354994)

  • 1. Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction.
    Zamilpa R; Lopez EF; Chiao YA; Dai Q; Escobar GP; Hakala K; Weintraub ST; Lindsey ML
    Proteomics; 2010 Jun; 10(11):2214-23. PubMed ID: 20354994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo matrix metalloproteinase-7 substrates identified in the left ventricle post-myocardial infarction using proteomics.
    Chiao YA; Zamilpa R; Lopez EF; Dai Q; Escobar GP; Hakala K; Weintraub ST; Lindsey ML
    J Proteome Res; 2010 May; 9(5):2649-57. PubMed ID: 20232908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of the left ventricle post-myocardial infarction to identify in vivo candidate matrix metalloproteinase substrates.
    Yabluchanskiy A; Li Y; de Castro Brás LE; Hakala K; Weintraub ST; Lindsey ML
    Methods Mol Biol; 2013; 1066():185-99. PubMed ID: 23955744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building a better infarct: Modulation of collagen cross-linking to increase infarct stiffness and reduce left ventricular dilation post-myocardial infarction.
    Voorhees AP; DeLeon-Pennell KY; Ma Y; Halade GV; Yabluchanskiy A; Iyer RP; Flynn E; Cates CA; Lindsey ML; Han HC
    J Mol Cell Cardiol; 2015 Aug; 85():229-39. PubMed ID: 26080361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citrate synthase is a novel in vivo matrix metalloproteinase-9 substrate that regulates mitochondrial function in the postmyocardial infarction left ventricle.
    de Castro Brás LE; Cates CA; DeLeon-Pennell KY; Ma Y; Iyer RP; Halade GV; Yabluchanskiy A; Fields GB; Weintraub ST; Lindsey ML
    Antioxid Redox Signal; 2014 Nov; 21(14):1974-85. PubMed ID: 24382150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD36 Is a Matrix Metalloproteinase-9 Substrate That Stimulates Neutrophil Apoptosis and Removal During Cardiac Remodeling.
    DeLeon-Pennell KY; Tian Y; Zhang B; Cates CA; Iyer RP; Cannon P; Shah P; Aiyetan P; Halade GV; Ma Y; Flynn E; Zhang Z; Jin YF; Zhang H; Lindsey ML
    Circ Cardiovasc Genet; 2016 Feb; 9(1):14-25. PubMed ID: 26578544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.
    Iyer RP; de Castro Brás LE; Patterson NL; Bhowmick M; Flynn ER; Asher M; Cannon PL; Deleon-Pennell KY; Fields GB; Lindsey ML
    J Mol Cell Cardiol; 2016 Nov; 100():109-117. PubMed ID: 27746126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPARC mediates early extracellular matrix remodeling following myocardial infarction.
    McCurdy SM; Dai Q; Zhang J; Zamilpa R; Ramirez TA; Dayah T; Nguyen N; Jin YF; Bradshaw AD; Lindsey ML
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H497-505. PubMed ID: 21602472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial Infarction Superimposed on Aging: MMP-9 Deletion Promotes M2 Macrophage Polarization.
    Yabluchanskiy A; Ma Y; DeLeon-Pennell KY; Altara R; Halade GV; Voorhees AP; Nguyen NT; Jin YF; Winniford MD; Hall ME; Han HC; Lindsey ML
    J Gerontol A Biol Sci Med Sci; 2016 Apr; 71(4):475-83. PubMed ID: 25878031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction.
    Lindsey ML; Escobar GP; Dobrucki LW; Goshorn DK; Bouges S; Mingoia JT; McClister DM; Su H; Gannon J; MacGillivray C; Lee RT; Sinusas AJ; Spinale FG
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H232-9. PubMed ID: 16126817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMP-9 signaling in the left ventricle following myocardial infarction.
    Iyer RP; Jung M; Lindsey ML
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H190-8. PubMed ID: 27208160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac aging is initiated by matrix metalloproteinase-9-mediated endothelial dysfunction.
    Yabluchanskiy A; Ma Y; Chiao YA; Lopez EF; Voorhees AP; Toba H; Hall ME; Han HC; Lindsey ML; Jin YF
    Am J Physiol Heart Circ Physiol; 2014 May; 306(10):H1398-407. PubMed ID: 24658018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship among LRP1 expression, Pyk2 phosphorylation and MMP-9 activation in left ventricular remodelling after myocardial infarction.
    Revuelta-López E; Soler-Botija C; Nasarre L; Benitez-Amaro A; de Gonzalo-Calvo D; Bayes-Genis A; Llorente-Cortés V
    J Cell Mol Med; 2017 Sep; 21(9):1915-1928. PubMed ID: 28378397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
    Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice.
    Jenke A; Schur R; Röger C; Karadeniz Z; Grüger M; Holzhauser L; Savvatis K; Poller W; Schultheiss HP; Landmesser U; Skurk C
    Physiol Rep; 2017 Dec; 5(24):. PubMed ID: 29263115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Ikeuchi M; Shiomi T; Matsusaka H; Kubota T; Imanaka-Yoshida K; Itoh T; Takeshita A
    Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1229-35. PubMed ID: 12775562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves LV function postmyocardial infarction.
    Mani SK; Kern CB; Kimbrough D; Addy B; Kasiganesan H; Rivers WT; Patel RK; Chou JC; Spinale FG; Mukherjee R; Menick DR
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(11):H1391-401. PubMed ID: 25795711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.
    Matsumura S; Iwanaga S; Mochizuki S; Okamoto H; Ogawa S; Okada Y
    J Clin Invest; 2005 Mar; 115(3):599-609. PubMed ID: 15711638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vivo interleukin-10 gene transfer down-regulates myocardial matrix metalloproteinase and myocardial collagen expressions in rats with acute myocardial infarction].
    Hu CY; Ding WH; Han XN; Chu SY; Hao YJ; Bu DF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Mar; 36(3):243-8. PubMed ID: 19099983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma fractionation enriches post-myocardial infarction samples prior to proteomics analysis.
    de Castro Brás LE; Deleon KY; Ma Y; Dai Q; Hakala K; Weintraub ST; Lindsey ML
    Int J Proteomics; 2012; 2012():397103. PubMed ID: 22778955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.